Nitroxolină Mip (Nitroxoline)

Nitroxolină Mip is used to manage bacterial infections of the urinary tract.

• Uncomplicated urinary tract infection: eliminates causative bacteria and relieves dysuria and frequency.
• Cystitis: treats bladder infection, reducing inflammation and promoting symptom resolution.
• Acute uncomplicated cystitis: provides rapid bacterial clearance and symptom improvement.

• Nitroxoline exerts its antibacterial effect by chelating divalent metal ions such as iron and magnesium, which are essential cofactors for bacterial enzymes. This chelation impairs bacterial adhesion, disrupts metabolic pathways, and inhibits key enzymes, leading to reduced bacterial growth and eventual eradication of susceptible urinary pathogens.

Nitroxolină Mip may cause adverse reactions that vary in frequency and severity.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Vomiting: occasional episodes after dosing.
• Abdominal pain: cramp‑like discomfort in the gastrointestinal tract.
• Headache: transient dull or throbbing pain.
• Rash: mild skin erythema or pruritus.
• Altered taste: metallic or bitter sensation.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction with airway compromise.
• Hepatic dysfunction: elevated liver enzymes or jaundice.
• Neutropenia: marked reduction in white blood cells.
• Thrombocytopenia: low platelet count leading to bleeding risk.
• Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.
• Interstitial nephritis: inflammation of kidney interstitium causing renal impairment.

Before prescribing Nitroxolină Mip, clinicians should consider several safety aspects.

• Renal function: evaluate creatinine clearance in patients with kidney disease.
• Hepatic function: monitor liver enzymes in individuals with liver impairment.
• Pregnancy: use only if the potential benefit justifies the unknown risk to the fetus.
• Elderly patients: start at the lowest effective dose and monitor for toxicity.
• Concomitant medications: review all drugs for possible interactions.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nitroxolină Mip can interact with other medicines, requiring careful assessment.

Major Interactions (Avoid)

• Nephrotoxic agents (e.g., aminoglycosides): may increase risk of kidney injury.
• Strong metal chelators (e.g., deferoxamine): can reduce nitroxoline absorption and efficacy.
• Co‑administration with other quinolone antibiotics: risk of additive toxicity.

Moderate Interactions (Monitor Closely)

• NSAIDs: may heighten gastrointestinal irritation.
• Warfarin: potential enhancement of anticoagulant effect, requiring INR monitoring.
• Diuretics: possible electrolyte disturbances; monitor serum levels.